Comparison of Contrast-Enhanced Ultrasonography with Gd-EOB-DTPA-enhanced MRI for the Diagnosis of Liver Metastases from Pancreatic Cancer

Comparison of Contrast-Enhanced Ultrasonography with Gd-EOB-DTPA-enhanced MRI for the Diagnosis of Liver Metastases from Pancreatic Cancer - Comparison of Contrast-Enhanced Ultrasonography with enhanced MRI for the Diagnosis of Liver Metastases from Pancreatic Cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028870

Enrollment

250

Registered

2017-08-28

Start date

2017-08-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

An intravenous bolus injection of Sonazoid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: cases of suspected of having a pancreatic cancer by contrast enhanced CT

Exclusion criteria

Exclusion criteria: serious complications severe mental illness allergy of egg or Sonazoid non-agreement case with this research unsuitable case

Design outcomes

Primary

Measure	Time frame
The diagnostic accuracies of CEUS compared with EOB MRI for liver metastases from pancreatic cancer	—

Countries

Japan

Contacts

Public ContactTakuya Ishikawa

Nagoya University Graduate School of Medicine Department of gastroenterology and Hepatology

ishitaku@med.nagoya-u.ac.jp052-744-2602

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026